Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Priothera
Priothera
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Priothera
Total Funding
$35.5 M
Priothera Summary
Company Summary
Overview
Priothera is a company that develops receptor modulators intended to improve the lives of patients suffering from hematological malignancies. Its receptor modulators reduce the egress of T cell subsets from lymphatic tissues.
Type
Private
Status
Active
Founded
2020
HQ
Dublin, IE
|
view all locations
Website
https://priothera.com/
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
healthtech
oncology
pharma
Homepage
Table of Contents
Key People
Locations
Competitors
Key People
Florent Gros,
Chief Executive Officer and Founder
Brice Suire,
Chief Financial Officer and Founder
Dhaval Patel,
Director
Marten Steen,
Director
and 2 others
Locations
View all
2 locations detected
Dublin, D
HQ
Ireland
88 Harcourt St, Saint Kevin's
Saint-Louis, Grand Est
France
57 Av. Général de Gaulle
Competitors and Similar Companies
Apexigen
Healthcare - Private
Hummingbird Bioscience
Healthcare - Private
GenFleet Therapeutics
Healthcare - Private
Remegen
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top